SeQuent Scientific Ltd
NSE:SEQUENT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
SeaWorld Entertainment Inc
NYSE:PRKS
|
US |
|
GoTo Gojek Tokopedia PT Tbk
IDX:GOTO
|
ID |
|
YIT Oyj
LSE:0GKA
|
FI |
|
J
|
JSR Corp
SWB:JYR
|
JP |
|
G
|
Guangdong Hotata Technology Group Co Ltd
SSE:603848
|
CN |
|
Elisa Oyj
OMXH:ELISA
|
FI |
|
G
|
Globetronics Technology Bhd
KLSE:GTRONIC
|
MY |
|
LT Foods Ltd
BSE:532783
|
IN |
|
Vimy Resources Ltd
ASX:VMY
|
AU |
|
C
|
Centrus Energy Corp
AMEX:LEU
|
US |
|
R
|
Routon Electronic Co Ltd
SSE:600355
|
CN |
|
A
|
aXichem AB (publ)
STO:AXIC A
|
SE |
|
V
|
VMS Industries Ltd
BSE:533427
|
IN |
|
Haitong International Securities Group Ltd
HKEX:665
|
HK |
|
V
|
VersaBank
TSX:VBNK
|
CA |
SeQuent Scientific Ltd
Intangible Assets
SeQuent Scientific Ltd
Intangible Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Intangible Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
SeQuent Scientific Ltd
NSE:SEQUENT
|
Intangible Assets
₹534.4m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
1%
|
CAGR 10-Years
13%
|
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Intangible Assets
₹100.9B
|
CAGR 3-Years
47%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
|
Cipla Ltd
NSE:CIPLA
|
Intangible Assets
₹19.2B
|
CAGR 3-Years
5%
|
CAGR 5-Years
1%
|
CAGR 10-Years
26%
|
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Intangible Assets
₹136.8B
|
CAGR 3-Years
32%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
|
Lupin Ltd
NSE:LUPIN
|
Intangible Assets
₹25.2B
|
CAGR 3-Years
24%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Intangible Assets
₹40.4B
|
CAGR 3-Years
5%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
SeQuent Scientific Ltd
Glance View
SeQuent Scientific Ltd. manufactures and produces veterinary pharmaceuticals and specialty chemicals. The company is headquartered in Bangalore, Karnataka. The company went IPO on 2016-03-10. The firm operates in the domains of animal health, in which it provides active pharmaceutical ingredient (APIs) and finished dosage formulations, and analytical services. The firm through its subsidiary, Alivira Animal Health Limited, offers APIs and formulations. Alivira Animal Health Limited has manufacturing facilities in five countries, including India. The Company’s subsidiary, Sequent Research Limited, is a contract research organization, which is engaged in analytical and biological analytical services to support the API, pharmaceutical, personal care and nutraceutical companies. Sequent Research Limited provides complete analytical solutions, including method validation, stability, microbiology for APIs and finished products in a variety of dosage forms as per pharmacopeial monographs, customer-developed methods or in-house method development.
See Also
What is SeQuent Scientific Ltd's Intangible Assets?
Intangible Assets
534.4m
INR
Based on the financial report for Jun 30, 2025, SeQuent Scientific Ltd's Intangible Assets amounts to 534.4m INR.
What is SeQuent Scientific Ltd's Intangible Assets growth rate?
Intangible Assets CAGR 10Y
13%
Over the last year, the Intangible Assets growth was -13%. The average annual Intangible Assets growth rates for SeQuent Scientific Ltd have been -8% over the past three years , 1% over the past five years , and 13% over the past ten years .
